Levocabastine Ameliorates Cyclophosphamide-induced Hepatotoxicity in Swiss Albino Mice: Modulation of Nrf2, NF-κB P65, Cleaved Caspase-3 and TGF-β Signaling Molecules

Overview

Journal J Mol Histol

Specialty Biochemistry

Date 2024 Nov 27

PMID 39602021

Authors

Wasim Akram

Abul Kalam Najmi

Syed Ehtaishamul Haque

Affiliations

Soon will be listed here.

Abstract

Background: Cyclophosphamide (CP)-induced hepatotoxicity is a significant problem in clinical settings. This study aimed to evaluate the protective effect of levocabastine (LEV) on CP-induced hepatotoxicity in Swiss albino mice.

Methods And Results: Mice were given CP (toxic drug) 200 mg/kg, i.p., once on the 7th day, and LEV 50 and 100 µg/kg, i.p., and fenofibrate (FF) 80 mg/kg, p.o., daily for 14 days. On the 15th day, blood and liver samples were collected to assess biological parameters. CP 200 mg/kg caused hepatotoxicity due to oxidative stress, inflammation, apoptosis, and fibrosis as manifested by a reduction in catalase, reduced glutathione (GSH), superoxide dismutase (SOD), and an increase in thiobarbituric acid reactive substance (TBARS), nitrite, tumor necrosis factor-alpha (TNF-α), interleukin-6 (IL-6), transforming growth factor-beta 1 (TGF-β1), interleukin-1β (IL-1β), alkaline phosphatase (ALP), alanine aminotransferase (ALT), aspartate aminotransferase (AST), and gamma-glutamyl transferase (GGT) levels. Cleaved caspase-3 and nuclear factor kappa-B (NF-κB) expression was also increased and nuclear factor erythroid 2-related factor (Nrf2) expression was decreased as confirmed by Immunohistochemical analysis. It also caused histopathological abnormalities and fibrosis as manifested by Hematoxylin-Eosin (H&E) and Masson's trichrome (MT) staining. These alterations were returned to almost normal when treated with LEV 100 µg/kg and FF 80 mg/kg. Thus, LEV protected CP-induced hepatotoxicity by reversing inflammation, apoptosis, fibrosis, oxidative stress, hepatic injury, and histopathological damages.

Conclusion: LEV can be helpful as an adjuvant in cancer patients who are on CP treatment, to minimize toxicity. However, its role in in-vivo cancer model is further needed to be confirmed.

References

Akamo A, Rotimi S, Akinloye D, Ugbaja R, Adeleye O, Dosumu O . Naringin prevents cyclophosphamide-induced hepatotoxicity in rats by attenuating oxidative stress, fibrosis, and inflammation. Food Chem Toxicol. 2021; 153:112266. DOI: 10.1016/j.fct.2021.112266. View

Akay H, Akay T, Secilmis S, Kocak Z, Donderici O . Hepatotoxicity after low-dose cyclophosphamide therapy. South Med J. 2007; 99(12):1399-400. DOI: 10.1097/01.smj.0000251467.62842.ad. View

Bielory L, Lien K, Bigelsen S . Efficacy and tolerability of newer antihistamines in the treatment of allergic conjunctivitis. Drugs. 2005; 65(2):215-28. DOI: 10.2165/00003495-200565020-00004. View

Croom E . Metabolism of xenobiotics of human environments. Prog Mol Biol Transl Sci. 2012; 112:31-88. DOI: 10.1016/B978-0-12-415813-9.00003-9. View

de Jonge M, Huitema A, Rodenhuis S, Beijnen J . Clinical pharmacokinetics of cyclophosphamide. Clin Pharmacokinet. 2005; 44(11):1135-64. DOI: 10.2165/00003088-200544110-00003. View

de Jonge M, Huitema A, Beijnen J, Rodenhuis S . High exposures to bioactivated cyclophosphamide are related to the occurrence of veno-occlusive disease of the liver following high-dose chemotherapy. Br J Cancer. 2006; 94(9):1226-30. PMC: 2361415. DOI: 10.1038/sj.bjc.6603097. View

de Souza V, Pereira T, Teixeira V, Carvalho H, Accioly Brelaz de Castro M, DAssuncao C . Bone marrow-derived monocyte infusion improves hepatic fibrosis by decreasing osteopontin, TGF-β1, IL-13 and oxidative stress. World J Gastroenterol. 2017; 23(28):5146-5157. PMC: 5537181. DOI: 10.3748/wjg.v23.i28.5146. View

Dooley S, Ten Dijke P . TGF-β in progression of liver disease. Cell Tissue Res. 2011; 347(1):245-56. PMC: 3250614. DOI: 10.1007/s00441-011-1246-y. View

Germoush M, Mahmoud A . Berberine mitigates cyclophosphamide-induced hepatotoxicity by modulating antioxidant status and inflammatory cytokines. J Cancer Res Clin Oncol. 2014; 140(7):1103-9. DOI: 10.1007/s00432-014-1665-8. View

10.

Hagar H, Husain S, Fadda L, Attia N, Attia M, Ali H . Inhibition of NF-κB and the oxidative stress -dependent caspase-3 apoptotic pathway by betaine supplementation attenuates hepatic injury mediated by cisplatin in rats. Pharmacol Rep. 2019; 71(6):1025-1033. DOI: 10.1016/j.pharep.2019.06.003. View

11.

He F, Ru X, Wen T . NRF2, a Transcription Factor for Stress Response and Beyond. Int J Mol Sci. 2020; 21(13). PMC: 7369905. DOI: 10.3390/ijms21134777. View

12.

Iqubal A, Syed M, Ali J, Najmi A, Haque M, Haque S . Nerolidol protects the liver against cyclophosphamide-induced hepatic inflammation, apoptosis, and fibrosis via modulation of Nrf2, NF-κB p65, and caspase-3 signaling molecules in Swiss albino mice. Biofactors. 2020; 46(6):963-973. DOI: 10.1002/biof.1679. View

13.

Iqubal A, Najmi A, Md S, Alkreathy H, Ali J, Syed M . Oral delivery of nerolidol alleviates cyclophosphamide-induced renal inflammation, apoptosis, and fibrosis via modulation of NF-κB/cleaved caspase-3/TGF-β signaling molecules. Drug Deliv. 2023; 30(1):2241661. PMC: 10946274. DOI: 10.1080/10717544.2023.2241661. View

14.

Jaiswal A . Nrf2 signaling in coordinated activation of antioxidant gene expression. Free Radic Biol Med. 2004; 36(10):1199-207. DOI: 10.1016/j.freeradbiomed.2004.02.074. View

15.

Khan V, Sharma S, Bhandari U, Sharma N, Rishi V, Haque S . Suppression of isoproterenol-induced cardiotoxicity in rats by raspberry ketone via activation of peroxisome proliferator activated receptor-α. Eur J Pharmacol. 2018; 842:157-166. DOI: 10.1016/j.ejphar.2018.10.034. View

16.

King P, Perry M . Hepatotoxicity of chemotherapy. Oncologist. 2001; 6(2):162-76. DOI: 10.1634/theoncologist.6-2-162. View

17.

Lores-Arnaiz S, Karadayian A, Gutnisky A, Rodriguez de Lores Arnaiz G . The low affinity neurotensin receptor antagonist levocabastine impairs brain nitric oxide synthesis and mitochondrial function by independent mechanisms. J Neurochem. 2017; 143(6):684-696. DOI: 10.1111/jnc.14232. View

18.

Luangmonkong T, Suriguga S, Mutsaers H, Groothuis G, Olinga P, Boersema M . Targeting Oxidative Stress for the Treatment of Liver Fibrosis. Rev Physiol Biochem Pharmacol. 2018; 175:71-102. DOI: 10.1007/112_2018_10. View

19.

Lyu H, Wang H, Li L, Zhu J, Chen F, Chen Y . Hepatocyte-specific deficiency of Nrf2 exacerbates carbon tetrachloride-induced liver fibrosis via aggravated hepatocyte injury and subsequent inflammatory and fibrogenic responses. Free Radic Biol Med. 2020; 150:136-147. DOI: 10.1016/j.freeradbiomed.2020.02.015. View

20.

Mahmoud A, Germoush M, Alotaibi M, Hussein O . Possible involvement of Nrf2 and PPARγ up-regulation in the protective effect of umbelliferone against cyclophosphamide-induced hepatotoxicity. Biomed Pharmacother. 2016; 86:297-306. DOI: 10.1016/j.biopha.2016.12.047. View